Background: Lymph‐vascular space invasion (LVSI) is an unfavorable prognostic factor in cervical cancer. Unfortunately, there are no current clinical tools for the preoperative prediction of LVSI.Purpose: To develop and validate an axial T₁ contrast‐enhanced (CE) MR‐based radiomics nomogram that incorporated a radiomics signature and some clinical parameters for predicting LVSI of cervical cancer preoperatively.Study Type: Retrospective.Population: In all, 105 patients were randomly divided into two cohorts at a 2:1 ratio.Field Strength/Sequence: T₁ CE MRI sequences at 1.5T.Assessment: Univariate analysis was performed on the radiomics features and clinical parameters. Multivariate analysis was performed to determine the optimal feature subset. The receiver operating characteristic (ROC) analysis was performed to evaluate the performance of prediction model and radiomics nomogram.Statistical Tests: The Mann–Whitney U‐test and the chi‐square test were used to evaluate the performance of clinical characteristics and LVSI status by pathology. The minimum‐redundancy/maximum‐relevance and recursive feature elimination methods were applied to select the features. The radiomics model was constructed using logistic regression.Results: Three radiomics features and one clinical characteristic were selected. The radiomics nomogram showed favorable discrimination between LVSI and non‐LVSI groups. The AUC was 0.754 (95% confidence interval [CI], 0.6326–0.8745) in the training cohort and 0.727 (95% CI, 0.5449–0.9097) in the validation cohort. The specificity and sensitivity were 0.756 and 0.828 in the training cohort and 0.773 and 0.692 in the validation cohort.Data Conclusion: T₁ CE MR‐based radiomics nomogram serves as a noninvasive biomarker in the prediction of LVSI in patients with cervical cancer preoperatively.Level of Evidence: 4Technical Efficacy: Stage 2J. Magn. Reson. Imaging 2019;49:1420–1426.

We report a convenient strategy to prepare ultrasmall Fe₃O₄ nanoparticles (NPs) coated with zwitterion L-cysteine (Cys) for enhanced T₁-weighted magnetic resonance (MR) imaging applications. The formed Fe₃O₄–PEG–Cys NPs possess antifouling properties, good r₁ relaxivity, excellent cytocompatibility and hemocompatibility, and can be used as a contrast agent for enhanced blood pool and tumor MR imaging.